Products
-
- 3D BBB Models
- Organ-on-a-Chip BBB ModelsTranswell Models3D BBB Models Culture Substrate
- 3D HydrogelsCollagensAnmial BBB ModelsCell Lines for BBB Modeling
- Immortalized CellsPrimary CellsStem Cells
Human Ornithine Aminotransferase ELISA Kit (AC2874)
Cat.#: ASET-1463
Specifications
Description Human Ornithine Aminotransferase ELISA Kit, a 90-minute assay kit, allows for the in vitro quantitative determination of human Ornithine Aminotransferase concentrations in serum, plasma, and other biological fluids. Size 96T Sample Type Serum, plasma or other biological fluids. Reactivity Human Unit 1 kit Packaging Kit of pre-coated 96 well microplates (12 x 8 well strips) Detection Type Colorimetric Assay Type Quantitative Sensitivity 0.224 mU/ml Precision Intra-assay CV: < 8%
Inter-assay CV: < 10%Product Range 5-80 mU/mL Assay Time ~90 min Storage Store the unopened kit at +4°C. Shipping Wet ice Citation Guidance If you use our product in a scientific publication, please cite it as "Ace Therapeutics Cat.#". Click here to submit your paper's PubMed ID (PMID) to receive rewards. Related Products
Cat.# Name Assay Type Price ASET-2111 Rat FADS2 ELISA Kit (AC3522) Quantitative inquiry ASET-2135 Human SNAP23 ELISA Kit (AC3546) Quantitative inquiry ASET-1906 Human LPPR4 ELISA Kit (AC3317) Quantitative inquiry ASET-2211 Mouse Myelin Oligodendrocyte Glycoprotein ELISA Kit (AC3622) Quantitative inquiry ASET-1710 Human 160 kD Neurofilament Medium ELISA Kit (AC3121) Quantitative inquiry ASET-2151 Mouse Adenosine A1 Receptor ELISA Kit (AC3562) Quantitative inquiry ASET-1018 Human GPRC5A ELISA Kit (AC2429) Quantitative inquiry ASET-2060 Porcine GDNF ELISA Kit (AC3471) Quantitative inquiry ASET-2412 Human Pet1 ELISA Kit (AC3823) Quantitative inquiry ASET-1943 Mouse NK-2R ELISA Kit (AC3354) Quantitative inquiry All of our products are intended for preclinical research use only and cannot be used to diagnose, treat or manage patients.
Ace Therapeutics is a global leading provider of stroke research services. We are committed to accelerating progress in stroke research and drug development.
Quick Links0Inquiry Basket